Abstract
Background
Management of head and neck cancers requires a multidisciplinary approach where surgery followed by radio and chemotherapy is the mainstay of treatment. The above-mentioned treatment can cause mucositis, a severely debilitating side effect. This can have a significant impact on quality of life. A recent advancing mode of drug delivery is the bioadhesive system. This interacts with mucosa by adhering to it and thereby improving the efficacy of the therapeutic agent delivered.
Aim and objective
The purpose of this systematic review is to evaluate the effectiveness of bioadhesives in reducing oral mucositis and relieving pain associated with mucositis in head and neck cancer patients receiving radio-chemotherapy.
Materials and method
Studies assessing the effectiveness of bioadhesives for the treatment of radiation-induced oral mucositis were retrieved from specialized databases (PubMed/MEDLINE, Scopus, ProQuest, Google Scholar, LILACS, OpenGrey) as well as institutional repositories. Data on incidence, pain reduction, resolution, and improvement of oral mucositis using bioadhesive were compiled. A Cochrane tool was used for randomized controlled trials and a JBI tool for non-randomized controlled trials and observational studies to assess the quality of included studies. Based on the eligible study data, a meta-analysis was conducted with STATA version 16, 2019 software, and 95% confidence intervals and p values greater than 0.05.
Results
A total of 15 studies were included which assessed the effectiveness of bioadhesives in managing mucositis and its associated pain. Studies included in the review described either reduction, resolution, or incidence of oral mucositis respectively. A total of three meta-analyses were conducted to assess the incidence of oral mucositis and the pain associated with it, as well as the reduction in incidence. Bioadhesives showed statistically significant differences in the incidence of severe mucositis (p = 0.04). A meta-analysis comparing bioadhesives efficacy in reducing mucositis and pain associated with it found no statistically significant differences (p = 0.36).
Conclusion
Bioadhesives are emerging as a novel drug delivery method for treating radio-chemotherapy-induced oral mucositis because of their rapid absorption and easy application. Regardless of its benefits, clinical trials comparing it with conventional treatment methods are necessary to assess its efficacy in treating oral mucositis.
Similar content being viewed by others
References
Fitzmaurice C (2018) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 2006 to 2016: a systematic analysis for the Global Burden of Disease study. Clin Oncol 20(36):1568–1568. https://doi.org/10.1200/jco.2018.36.15_suppl.1568
Mehanna H, Paleri V, West CML, Nutting C (2011) Head and neck cancer-part 1: epidemiology, presentation, and preservation. Clin Otolaryngol 36:65–68. https://doi.org/10.1111/j.1749-4486.2010.02231.x
Pignon J-P, le Maître A, Maillard E, Bourhis J (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiat Oncol J 92:4–14. https://doi.org/10.1016/j.radonc.2009.04.014
Lo Nigro C, Denaro N, Merlotti A, Merlano M (2017) Head and neck cancer: improving outcomes with a multidisciplinary approach. Cancer Manag Res 9:363–371. https://doi.org/10.2147/cmar.s115761
D’Hondt L, Lonchay C, Andr M, Canon J-L (2006) Oral mucositis induced by anticancer treatments: physiopathology and treatments. Ther Clin Risk Manag 2:159–168. https://doi.org/10.2147/tcrm.2006.2.2.159
Kin-fong Cheng K, Ka Tsui Yuen J (2006) A pilot study of chlorhexidine and benzydamine oral rinses for the prevention and treatment of irradiation mucositis in patients with head and neck cancer. Cancer Nurs 29:423–430. https://doi.org/10.1097/00002820-200609000-00012
Stokman MA, Spijkervet FKL, Boezen HM, Schouten JP, Roodenburg JLN, de Vries EGE (2006) Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses. J Dent Res 85:690–700. https://doi.org/10.1177/154405910608500802
Rubenstein EB, Peterson DE, Schubert M et al (2044) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 101(8):1921–1921. https://doi.org/10.1002/cncr.20664
Khammissa RAG, Wood NH, Meyerov R, Lemmer J, Raubenheimer EJ, Feller L (2011) primary oral tuberculosis as an indicator of HIV infection. Pathol Res Pract 2011(20):1–4. https://doi.org/10.4061/2011/893295
Hejna M, Köstler WJ, Raderer M, Steger GG, Brodowicz T, Scheithauer W et al (2001) Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF. Eur J Cancer 37:1994–2002. https://doi.org/10.1016/s0959-8049(01)00132-0
Sonis ST (2004) The pathobiology of mucositis. Nat Rev Cancer 4:277–284. https://doi.org/10.1038/nrc1318
Lanzos I, Herrera D, Santos S, Connor A, Pena C, Lanzos E et al (2010) Mucositis in irradiated cancer patients: effects of an antiseptic mouthrinse. Medicina Oral Patología Oral y Cirugia Bucal, pp e732–e738. https://doi.org/10.4317/medoral.15.e732
Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. dental clinics of North America. 2008;52(1):61–77. https://doi.org/10.1016/j.cden.2007.10.002
Riley P, Glenny A-M, Worthington HV, Littlewood A, Clarkson JE, MG MC (2015) In: Riley P (ed) Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd011552
Raber-Durlacher JE, von Bültzingslöwen I, Logan RM, Bowen J, Al-Azri AR et al (2012 Sep 18) Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer 21(1):343–355. https://doi.org/10.1007/s00520-012-1594-5
Ariyawardana A, Cheng KKF, Kandwal A, Tilly V, Al-Azri AR et al (2019) Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 27(10):3985–3995. https://doi.org/10.1007/s00520-019-04888-w
Raza A, Karimyan N, Watters A, Emperumal CP, Al-Eryani K, Enciso R (2022 Jun 10) Efficacy of oral and topical antioxidants in the prevention and management of oral mucositis in head and neck cancer patients: a systematic review and meta-analyses. Supportive Care in Cancer 30(11):8689–8703. https://doi.org/10.1007/s00520-022-07190-4
Campos TM, do Prado Tavares Silva CA, APT S, Sobral SS, MFSD R, Bussadori SK et al (2020) Photobiomodulation in oral mucositis in patients with head and neck cancer: a systematic review and meta-analysis followed by a cost-effectiveness analysis. Support Care Cancer 28(12):5649–5659. https://doi.org/10.1007/s00520-020-05613-8
De Sanctis V, Bossi P, Sanguineti G, Trippa F, Ferrari D, Bacigalupo A et al (2016) Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: literature review and consensus statements. Crit Rev Oncol Hematol 100:147–166. https://doi.org/10.1016/j.critrevonc.2016.01.010
Massa S, Fouad A, Ebrahimi M, PLS M (2021) Emerging trends in oral mucoadhesive drug delivery for head and neck cancer. In: Early Detection and Treatment of Head & Neck Cancers. Springer, pp 199–217. https://doi.org/10.1007/978-3-030-69852-2_9
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savović J, Schulz KF, Weeks L, Sterne JA (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj 18:343. https://doi.org/10.1136/bmj.d5928
Tufanaru C, Munn Z, Aromataris E, Campbell J, Hopp L (2019) Chapter 3: systematic reviews of effectiveness. JBI Reviewer’s Manual. https://doi.org/10.46658/jbirm-17-03
Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetic R et al (2019) Chapter 7: systematic reviews of etiology and risk. JBI Reviewer’s Manual. https://doi.org/10.46658/jbirm-17-06
GRADE Working Group (2004) Grading quality of evidence and strength of recommendations. BMJ 328(7454):1490. https://doi.org/10.1136/bmj.328.7454.1490
Allison RR, Ambrad AA, Arshoun Y, Carmel RJ, Ciuba DF, Feldman E et al (2014) Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck. Cancer 11(120):1433–1440. https://doi.org/10.1002/cncr.28553
Diaz-Sanchez RM, Pachon-Ibanez J, Marin-Conde F, Rodriguez-Caballero A, Gutierrez-Perez JL, Torres-Lagares D (2015) Double-blind, randomized pilot study of bioadhesive chlorhexidine gel in the prevention and treatment of mucositis induced by chemoradiotherapy of head and neck cancer. Medicina Oral Patología Oral y Cirugia Bucal, pp e378–e385. https://doi.org/10.4317/medoral.20338
Isfahani M, Pakravan F, Ghalayani P, Emami H, Noorshargh P (2019) A novel formulation for radiotherapy-induced oral mucositis: triamcinolone acetonide mucoadhesive film. J Res Med Sci 24:63. https://doi.org/10.4103/jrms.jrms_456_18
Ghalayani P, Emami H, Pakravan F, Nasr Isfahani M (2014) Comparison of triamcinolone acetonide mucoadhesive film with licorice mucoadhesive film on radiotherapy-induced oral mucositis: a randomized double-blinded clinical trial. Asia Pac J Clin Oncol 13(2):e48–e56. https://doi.org/10.1111/ajco.12295
Lozano A, Marruecos J, Rubió J, Farré N, Gómez-Millán J, Morera R et al (2021) Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment. Transl Oncol 18(23):1801–1810. https://doi.org/10.1007/s12094-021-02586-w
Naidu MU, Ramana GV, Ratnam SV, Sudhavani T, Jaganath K, Naidu R, Roy P, Suresh P, Rani PU, Mohan IK (2005) A Randomised, double-blind, parallel, placebo-controlled study to evaluate the efficacy of MF 5232 (Mucotrol™), a concentrated oral gel wafer, in the treatment of oral mucositis. Drugs in R & D 6:291–298. https://doi.org/10.2165/00126839-200506050-00005
Noronha V, Araujo G, Gomes R, Iwanaga S, Barbosa M, Abdo E et al (2014) Mucoadhesive propolis gel for prevention of radiation-induced oral mucositis. Curr Clin Pharmacol 5(9):359–364. https://doi.org/10.2174/1574884709666140205210051
Oguchi M, Shikama N, Sasaki S, Gomi K, Katsuyama Y, Ohta S, Takei K, Arakawa K, Sone S (1998) Mucosa-adhesive water-soluble polymer film for treatment of acute radiation-induced oral mucositis. Int J Radiat Oncol Biol Phys 15(40):1033–1037. https://doi.org/10.1016/s0360-3016(97)00903-6
Wei J, Wu J, Wang H, Wang B, Zhao T, Meng L et al (2021) A bioadhesive barrier-forming oral liquid gel improved oral mucositis and nutritional status in patients with head and neck cancers undergoing radiotherapy: a retrospective single center study. Front Oncol 22:11. https://doi.org/10.3389/fonc.2021.617392
Alterio D, Jereczek-Fossa BA, Zuccotti GF, Leon ME, Omodeo Sale E, Pasetti M et al (2006) Tetracaine oral gel in patients treated with radiotherapy for head-and-neck cancer: final results of a phase II study. Int J Radiat Oncol Biol Phys 64:392–395. https://doi.org/10.1016/j.ijrobp.2005.07.301
Barber C, Powell R, Ellis A, Hewett J (2006) Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis. Support Care Cancer 28(15):427–440. https://doi.org/10.1007/s00520-006-0171-1
Giralt J, Tao Y, Kortmann R-D, Zasadny X, Contreras-Martinez J, Ceruse P et al (2020) Randomized phase 2 trial of a novel clonidine mucoadhesive buccal tablet for the amelioration of oral mucositis in patients treated with concomitant chemoradiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys 106:320–328. https://doi.org/10.1016/j.ijrobp.2019.10.023
Hadjieva T, Cavallin-Ståhl E, Linden M, Tiberg F (2014) Treatment of oral mucositis pain following radiation therapy for head-and-neck cancer using a bioadhesive barrier-forming lipid solution. Support Care Cancer 18(22):1557–1562. https://doi.org/10.1007/s00520-014-2117-3
Kabasawa Y, Ito K, Tokura S, Takazawa I, Yoshida N, Nakanishi T et al (2022) Clinical investigation of use of Episil® oral solution in oral mucositis during radiotherapy for head and neck cancer, vol 14. research square. https://doi.org/10.21203/rs.3.rs-1210506/v1
Soutome S, Yanamoto S, Kawashita Y, Yoshimatsu M, Murata M, Kojima Y et al (2021) Effects of a bioadhesive barrier-forming oral liquid on pain due to radiation-induced oral mucositis in patients with head and neck cancer: a randomized crossover, preliminary study. J Dent Sci 16:96–100. https://doi.org/10.1016/j.jds.2020.07.006
Naidu MUR, Ramana GV, Rani PU, Mohan Iyyapu K, Suman A, Roy P (2004) Chemotherapy-induced and/or radiation therapy-induced oral mucositis-complicating the treatment of cancer. Neoplasia 6:423–431. https://doi.org/10.1593/neo.04169
Raber-Durlacher JE, Elad S, Barasch A (2010) Oral mucositis. Oral Oncol 46:452–456. https://doi.org/10.1016/j.oraloncology.2010.03.012
Sonis ST (2009) Mucositis: the impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol 45:1015–1020. https://doi.org/10.1016/j.oraloncology.2009.08.006
Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB (2003) The burdens of cancer therapy. Cancer 18(98):1531–1539. https://doi.org/10.1002/cncr.11671
Nonzee NJ, Dandade NA, Markossian T, Agulnik M, Argiris A, Patel JD et al (2008) Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis. Cancer 15(113):1446–1452. https://doi.org/10.1002/cncr.23714
Yuan A, Sonis S (2014) Emerging therapies for the prevention and treatment of oral mucositis. Expert Opinion on Emerging Drugs 8(19):343–351. https://doi.org/10.1517/14728214.2014.946403
Worthington HV, Clarkson JE, Bryan G, Furness S, Glenny A-M, Littlewood A et al (2010) In: Worthington HV (ed) Interventions for preventing oral mucositis for patients with cancer receiving treatment, vol 8. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd000978.pub4
Kassab S, Cummings M, Berkovitz S, van Haselen R, Fisher P (2009) Homeopathic medicines for adverse effects of cancer treatments, vol 15. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd004845.pub2
Stokman MA, Spijkervet FKL, Boezen HM, Schouten JP, Roodenburg JLN, de Vries EGE (2006) Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses. Dent Res J 85:690–700. https://doi.org/10.1177/154405910608500802
Quinn B, Botti S, Kurstjens M, Marguiles A, Orlando L, Potting C, et al. European oral care in cancer group oral care guidance and support contents. 1st ed
UK Oral Mucositis in Cancer Group Oral Mucositis Guidelines. (2015) Mouth care guidance and support in cancer and palliative care. http://www.ukomic.co.uk/documents/UK_OM_Guidelines.pdf. Accessed 27 Dec 2022
Murdock JL, Reeves DJ (2019) Chemotherapy-induced oral mucositis management: a retrospective analysis of MuGard, Caphosol, and standard supportive care measures. J Oncol Pharm Pract 29(26):521–528. https://doi.org/10.1177/1078155219850298
Fini A, Bergamante V, Ceschel GC (2011) Mucoadhesive gels designed for the controlled release of chlorhexidine in the oral cavity. Pharmaceutics 3:665–679. https://doi.org/10.3390/pharmaceutics3040665
Karki S, Kim H, Na S-J, Shin D, Jo K, Lee J (2016) Thin films as an emerging platform for drug delivery. Asian J Pharm Sci 11:559–574. https://doi.org/10.1016/j.ajps.2016.05.004
Barauskas J, Christerson L, Wadsäter M, Lindström F, Lindqvist A-K, Tiberg F (2014) Bioadhesive lipid compositions: self-assembly structures, functionality, and medical applications. Mol Pharmaceutics 27(11):895–903. https://doi.org/10.1021/mp400552u
Timur SS, Yüksel S, Akca G, Şenel S (2019) Localized drug delivery with mono and bilayered mucoadhesive films and wafers for oral mucosal infections. Int J Pharm 559:102–112. https://doi.org/10.1016/j.ijpharm.2019.01.029
Nokhodchi A, Raja S, Patel P, Asare-Addo K (2012) The role of oral controlled release matrix tablets in drug delivery systems. Bioimpacts 2:175–187. https://doi.org/10.5681/bi.2012.027
Funding
This was a self-funded systematic review and meta-analysis and did not receive any specific grants/funding from any funding agency in any of the sectors.
Author information
Authors and Affiliations
Contributions
Dr. Jayapriya T: conceptualization and protocol development, methodology, data collection and extraction, bias assessment, meta-analysis, and manuscript writing. Dr. Vaishali Keluskar: conceptualization, methodology, data collection and extraction, bias assessment, manuscript—review, and editing. Dr. Vasanti Lagali-Jirge: supervision, validation, visualization, bias assessment, manuscript—review, and editing. Dr. Sridhar M: data curation, supervision, writing review, and editing.
Corresponding author
Ethics declarations
Ethics approval
This is a systematic review and meta-analysis that involves assessment of studies, and hence, ethical clearance was not sought for.
Consent to participate
This is a systematic review and meta-analysis does not involve any human or animal intervention, and hence, consent was not mandatory.
Consent for publication
The authors declare that they are willing to publish this article and data will be shared upon reasonable request.
Competing interests
The authors declare no competing interests.
Additional information
Other information
Registration and protocol: Protocol for this systematic review was prepared before the start of the review and was registered in the International Prospective Register of Systematic Reviews (PROSPERO) maintained by the Centre of Reviews and Dissemination, University of York, York, UK (Ref No. CRD42022340445), which can be accessed through (https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022340445). The current systematic review was written in concordance with the preferred reporting items for the systematic review and meta-analysis (PRISMA) 2020 statement.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jayapriya, T., Keluskar, V., Lagali-Jirge, V. et al. Efficacy of bioadhesives in the management of oral mucositis in patients undergoing radio-chemotherapy for treatment of head and neck cancer—a systematic review and meta-analysis. Support Care Cancer 31, 470 (2023). https://doi.org/10.1007/s00520-023-07920-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00520-023-07920-2